pyrroles has been researched along with Central Nervous System Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badros, A; Dhakal, B; Hari, P; Kwok, Y; MacLaren, A; Richardson, P; Singh, Z; Trikha, M | 1 |
| Bocchia, M; Brambilla, CZ; Candi, V; Gozzetti, A; Papini, G; Sirianni, S | 1 |
| Banerjee, A; Blaney, S; Boyett, JM; Friedman, H; Fruscio, R; Geyer, R; Goldman, S; Kieran, MW; Kun, LE; Macdonald, T; Packer, R; Phillips, P; Pollack, I; Poussaint, TY; Supko, JG; Wallace, D | 1 |
| Chaskis, C; De Greve, J; Duerinck, J; Dujardin, M; Everaert, H; Lv, S; Michotte, A; Neyns, B; Nupponen, N; Sadones, J; Tynninen, O | 1 |
| Gállego Pérez-Larraya, J; Reyes-Botero, G; Sanson, M | 1 |
1 review(s) available for pyrroles and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Second Generation Proteasome Inhibitors in Multiple Myeloma.
Topics: Animals; Boronic Acids; Bortezomib; Central Nervous System Neoplasms; Drug Discovery; Humans; Lactones; Multiple Myeloma; Neoplasm Recurrence, Local; Oligopeptides; Proteasome Inhibitors; Pyrroles; Threonine | 2017 |
2 trial(s) available for pyrroles and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.
Topics: Adolescent; Angiogenesis Inhibitors; Anticonvulsants; Arthralgia; Central Nervous System Neoplasms; Child; Drug Interactions; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Liver; Male; Maximum Tolerated Dose; Protein Kinase Inhibitors; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Treatment Outcome; Young Adult | 2009 |
Phase II study of sunitinib malate in patients with recurrent high-grade glioma.
Topics: Adult; Aged; Antineoplastic Agents; Central Nervous System Neoplasms; Cerebrovascular Circulation; Disease Progression; Female; Glioma; Humans; Indoles; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrroles; Pyrrolidinones; Receptors, Platelet-Derived Growth Factor; Recurrence; Regional Blood Flow; Sunitinib; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
2 other study(ies) available for pyrroles and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Marizomib for central nervous system-multiple myeloma.
Topics: Adult; Central Nervous System Neoplasms; Humans; Lactones; Male; Middle Aged; Multiple Myeloma; Pyrroles | 2017 |
Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia.
Topics: Adult; Antineoplastic Agents; Brain; Central Nervous System Neoplasms; Hemangioblastoma; Humans; Indoles; Magnetic Resonance Imaging; Male; Polycythemia; Pyrroles; Spinal Cord; Sunitinib | 2012 |